Introduction
Since the recognition of fetal alcohol syndrome (FAS), alcohol has been shown to produce a wide spectrum of physical, neurological, cognitive and ophthalmological aberrations, now known as fetal alcohol spectrum disorders (FASD).1–15 The prototypical features of FAS are small palpebral fissures, a thin upper lip, a smooth philtrum, growth restrictions and central nervous system abnormalities (figure 1).1–3 8 16–18 Although previous studies have shown that small palpebral fissures are not the only ophthalmological features occurring frequently in children with FASD,9 11 13 19 the role of ophthalmological assessment in the work-up of FASD may be underestimated.
Alcohol use during pregnancy is a public health problem worldwide. A meta-analysis estimated that over 100 000 children around the world are born with FAS every year.20 The incorporation of the diagnosis ‘neurodevelopmental disorder – prenatally exposed’ into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition is a recognition of the association between alcohol exposure and behavioural and cognitive deficits. Within this wider spectrum of prenatal alcohol exposure (PAE), there is less agreement on what constitutes an alcohol-related aetiological diagnosis,21 22 and several sets of diagnostic criteria are used around the world to diagnose FASD. However, the key features of FAS in each set of criteria are the same: growth deficiency, facial dysmorphology and neurobehavioural impairment (figure 1).2 3 16–18
Ophthalmological findings, such as subnormal visual acuity, refractive errors, motility disorders, strabismus, and abnormalities of the retinal vessels and optic head, are frequently found in individuals with FASD, but these ophthalmological findings are also found in children with, for example, attention deficit/hyperactivity disorder (ADHD), as well as prematurely born children.23 24 On the other hand, both ADHD and prematurity are frequently found in children diagnosed with FASD.4 5 8 To what extent this co-occurrence is caused by confounding alcohol exposure is unknown, and clinically discriminating between alcohol exposure and other factors remains a challenge. Strabismus and refractive errors may cause amblyopia and visual impairment, which are treatable if found in early childhood, but if not treated may present additional problems for already affected individuals. Moreover, other groups with neurodevelopmental syndromes and genetic disorders may also present with similar ophthalmological abnormalities, although other clinical symptoms are usually present as well.
The medical diagnostic process is probabilistic in nature.25 Arriving at a seemingly dichotomous ‘yes or no’ answer to a diagnosis is guided by a probabilistic weighing of history, findings and tests, where the overarching question is: ‘What is the probability that the patient has this diagnosis, given the information and results?’ In this process, information and tests unspecific to the diagnosis in question help to adjust the probabilities of the diagnosis in a useful way. Analogous to supportive laboratory investigations, a complementary eye diagnostic tool could provide independent verification for clinicians, thus strengthening and helping FASD diagnostics. However, to be of use, findings must differentiate between FASD and children with other conditions presenting with similar symptoms. It should also be considered that anthropometric criteria are less evident in adulthood, while cognitive impairment and psychiatric morbidity are more evident in adults with FASD.4 5 26 27
The aims of this study were threefold: first, to develop and propose a complementary and easy-to-use tool based on ophthalmological findings to support an FASD diagnosis; second, to validate the FASD Eye Code’s capacity to discriminate FASD eye findings from prematurity, growth restriction and ADHD without diagnosed FASD; and third, to test the tool in long-term follow-up of individuals with FASD from childhood to young adulthood. In addition, the tool should be useful both in eye clinics and elsewhere, allowing use in outreach and epidemiological surveys of FASD in different communities, while simultaneously identifying treatable deficits requiring management no matter what the cause.